Cargando…

Constitutively Active Androgen Receptor in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the predominant type of liver cancer and a leading cause of cancer-related death globally. It is also a sexually dimorphic disease with a male predominance both in HCC and in its precursors, non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montgomery, Emma J., Xing, Enming, Campbell, Moray J., Li, Pui-Kai, Blachly, James S., Tsung, Allan, Coss, Christopher C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699340/ https://www.ncbi.nlm.nih.gov/pubmed/36430245 http://dx.doi.org/10.3390/ijms232213768

Ejemplares similares

SAT021 Development Of Niclosamide Analogs For Treatment Of Androgen Receptor Positive Hepatocellular Carcinoma
por: Jordan Montgomery, Emma, et al.
Publicado: (2023)

Hormone stimulation of androgen receptor mediates dynamic changes in DNA methylation patterns at regulatory elements
por: Dhiman, Vineet K., et al.
Publicado: (2015)

The androgen receptor as an emerging target in hepatocellular carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism
por: Coss, Christopher C, et al.
Publicado: (2014)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
por: Henzler, Christine, et al.
Publicado: (2016)

Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis
por: Oduwole, Olayiwola O., et al.
Publicado: (2018)

Nuclear receptors and the Warburg effect in cancer
por: Thome, James L., et al.
Publicado: (2014)

Deletion of Nuclear Receptor Constitutive Androstane Receptor CAR Increases Anxiety and Lowers Androgen Levels
por: Hernandez, Juan P, et al.
Publicado: (2021)

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
por: Ali, Mahmoud A, et al.
Publicado: (2017)

The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma
por: Acosta-Lopez, S., et al.
Publicado: (2020)

Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma
por: Song, Huijuan, et al.
Publicado: (2020)

Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks
por: Helms, Timothy H., et al.
Publicado: (2021)

Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma
por: Jiang, Lupin, et al.
Publicado: (2016)

Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells
por: Cottard, Félicie, et al.
Publicado: (2013)

Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2020)

Vitamin D Receptor Signaling and Cancer
por: Campbell, Moray J., et al.
Publicado: (2017)

Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?
por: Goulioumis, Anastasios K., et al.
Publicado: (2011)

Therapeutic androgen receptor ligands
por: Allan, George F., et al.
Publicado: (2003)

Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
por: He, Yundong, et al.
Publicado: (2018)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Nuclear Receptor Coregulators in Hormone-Dependent Cancers
por: Jafari, Hedieh, et al.
Publicado: (2022)

Durable Expression of Minicircle DNA-Liposome-Delivered Androgen Receptor cDNA in Mice with Hepatocellular Carcinoma
por: Chang, Tian-You, et al.
Publicado: (2014)

Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma
por: Jiang, Guangyi, et al.
Publicado: (2020)

Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression
por: Han, Qiuju, et al.
Publicado: (2020)

PMON251 Loss of Constitutive Androstane Receptor, CAR reduces the serum androgens levels and alters reproductive function
por: Asokakumar, Anjana, et al.
Publicado: (2022)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
por: To, Kenneth K. W., et al.
Publicado: (2023)

The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
por: Long, Mark D., et al.
Publicado: (2018)

Androgen Receptor Gene Variants in New Cases of Equine Androgen Insensitivity Syndrome
por: Villagomez, Daniel A.F., et al.
Publicado: (2020)

Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
por: Yazdani, Hamza O., et al.
Publicado: (2019)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Hepatectomy in a case of hepatocellular carcinoma with constitutional indocyanine green excretory defect
por: Nakatake, Richi, et al.
Publicado: (2018)

Hepatocellular carcinoma in body builders; an emerging rare but serious complication of androgenic anabolic steroid use
por: Woodward, Christopher, et al.
Publicado: (2019)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
por: Sherwood, E. R., et al.
Publicado: (1998)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013)

Prognostic relevance of androgen receptor expression in renal cell carcinomas
por: Foersch, Sebastian, et al.
Publicado: (2017)

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells
por: Shafi, Ayesha A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ti68u8g7all7dcbtid6erni9fi